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Gene targetingThe NIMA-related kinases (NRK or Nek) are emerging as conserved and crucial regulators of mitosis and cilia for-
mation. The microtubule (MT) network has long been suspected as a major target of the Neks. However, the
underlying mechanism remains unclear. Using the PlusTipTracker software, recently developed by the Danuser
group, we followed the consequences of alterations in Nek7 levels on MT dynamic instability. siRNA-mediated
downregulation of Nek7 in HeLa cells resulted in lower speeds of MT growth and catastrophe, reduction of the
relative time spent in catastrophe, and considerably lowered the overall MT dynamicity. Co-expression of
Nek7 with the siRNA treatment rescued the MT phenotypes, while ectopic overexpression of Nek7 yielded
inverse characteristics compared to Nek7 downregulation.MT dynamics inmouse embryonic ﬁbroblasts derived
from targeted null mutants for Nek7 recapitulated the siRNA downregulation phenotypes. Precise MT dynamic
instability is critical for accurate shaping of the mitotic spindle and for cilium formation, and higher MT
dynamicity is associated with tumorigenicity. Thus, our results can supply a mechanistic explanation for Nek in-
volvement in these processes.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The conserved NIMA-related family of Ser/Thr kinases has been
mainly linked to mitotic entrance and progression, and to cilia forma-
tion. The founding member of the family, Aspergillus nidulans NIMA ki-
nase, is involved in several aspect of mitotic entrance including
chromatin condensation, spindle organization, and nuclear envelope
breakdown [1,2]. NIMA-related kinases are found in almost all eukary-
otes, and in protists theyweremainly implicated in cilia/ﬂagella stability
and length [3]. Potential direct effect on protists' cilia microtubule (MT)
stability is suggested by the ﬁnding that a Nek kinase from the
trypanosomatid Crithidia displays tubulin polyglutamylation activity
[4], and by the MT severing activity of a NIMA-related kinase during
deﬂagellation in Chlamydomonas [5]. Eleven NIMA-related kinases
(Neks) exist in vertebrates, and the major functions attributed to them
are related to centrosome structure and dynamics, and mitotic spindle
assembly [6,7]. Similarly to the documented roles of the NIMA-related
kinases in protists, Nek1 and Nek8 have been shown to be involved in
primary cilium formation and length [8,9]. The ciliary phenotypes of
Nek1 and Nek8 have been postulated to be linked to basal body func-
tioning or axonemalMT organization [10–12]. However, data in support
of this hypothesis is still missing. Involvement in postmitotic MTs;MEF,mouse embryonicﬁbro-
mall interfering RNA;+TIP, plus
972 3738 4058.
l rights reserved.organization has been documented for Nek3, which affects neuronal
MT acetylation, presumably by modulating HDAC6 activity [13].
Three Nek kinases, Nek9 (Nercc1) and the closely related Nek6 and
Nek7 kinases, compose a mitotic signaling cascade. Nek9, downstream
of Plk1, phosphorylate Nek6 and Nek7 [14,15]. The phosphorylation,
as well as the physical interaction between Nek9 and Nek6/7 [16], acti-
vates Nek6/7. Reduction in the levels or activity of each of these three ki-
nases results in similar mitotic phenotypes, including disorganized
spindle and failure to accurately separate the centrosomes [6,17,18]. In
addition, downregulation of Nek6 or Nek7, and gene targeting of Nek7
revealed a role for these kinases in cytokinesis completion [19–21]. A
common possible theme in Nek6/7/9 phenotypes is the regulation of
mitotic MT nucleation and spindle formation. However, two observa-
tions indicate an additional role for Nek6/7 signaling in interphase MT:
A. The highest levels of nek6 and nek7 RNAs are speciﬁcally localized
in postmitotic neurons [22]. B. It was shown recently that Nek7 is re-
quired for interphase recruitment of the centrosomal pericentriolarma-
terials (PCM) and for centrosome duplication [23] (it should be noted
that these results are controversial and were not observed by Sdelci et
al. [24]). Even though the molecular mechanisms by which Nek7 affect
PCM recruitment were not established, it could strengthen the supposi-
tion that Nek7 is involved in MT-dependent transportation or MT
stability.
MT are highly dynamic ﬁlaments that undergo successive phases of
slow polymerization (growth), rapid shrinkage (catastrophe) and pause,
a property designated dynamic instability [25,26]. Dynamic instability en-
ables growing MT to explore their surroundings, and to constantly orga-
nize the MT network according to local signals. A growing list of factors
were reported to inﬂuence the tendency of the MT to initiate growth or
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though an intimate connection between the Nek kinases and theMT net-
work has been repeatedly anticipated in the literature [6,7], the inﬂuence
of these kinases onMTdynamics has not yet been explored. In the current
study, we used the EB3-GFP protein [29], a plus end binding protein
marker (+TIP), to follow and calculate MT dynamics parameters in
cells in which the levels of Nek7 have been down- or upregulated. The
analyses took advantage of the recently developed PlusTipTracker soft-
ware, a Matlab-based software package developed by Danuser lab
[30,31]. We found that the MT dynamic instability is dependent on
Nek7 levels. Reduction in Nek7 levels resulted in slower interphase MT
growth and shrinkage speeds, and considerably slower MT dynamicity.
Nek7 ectopic overexpression yielded inverse MT parameters. Thus Nek7
mitotic phenotypes, and probably the phenotypes of additional Nek ki-
nases, could be at least partially explicable by Nek kinases inﬂuence on
MT dynamics.
2. Materials and methods
2.1. Cell culture and transfection
HeLa andMEF cells were grown in Gibco DMEM supplementedwith
10% heat-inactivated fetal bovine serum(FBS), 100 IU/ml penicillin, and
100 μg/ml streptomycin at 37 °C in a 5% CO2 atmosphere. HeLa cells
were transfected transiently using different expression plasmids with
Metafectene reagent (Biontex) in accordance with the manufacturer's
protocol. Double-strand siRNA transfection was achieved using
Metafectene Pro (Biontex) reagent. Cells were analyzed for endogenous
and ectopic Nek7 24 h post transfection, or 48 h post transfection if the
experiment include siRNA introduction to the cells. The oligonucleo-
tides used for Nek7 were: siNek7-1: GCAACUCAACCAUCCAAAUdTdT,
siNek7-2: AUAUUAACUAACUGUCGGAGdTdT [20] and the control
scrambled-siRNA: GCACUAACCUACCAACAAUdTdT (Invitrogen).
MEF cells that were isolated from 13.5-day-pregnant mice, as de-
scribed previously [9], were transfected by using an AmaxaNucleofector
Primary Fibroblasts Kit apparatus (Amaxa Biosystems) in accordance
with the manufacturer's protocol (Nucleofector program A-23 with
5 μg DNA per 2*106 cells). As culture conditions could inﬂuence MT dy-
namic instability, in all experiments the control and the experimental
groups were cultured and treated in parallel. Full length Nek7 construct
taggedwith his-myc at the c-terminus (c-myc-Nek7)was described be-
fore [18]. TheHeLa cells used for the c-myc-Nek7 overexpression exper-
iments (and their c-myc control) were derived from a different stock
and their baseline dynamic parameters were slightly different.
2.2. Fluorescence microscopy and live-cell imaging
Cellswere seeded 48–72 h prior to video imaging on glass-bottomed
35 mm tissue culture plates (MatTek, Ashland, MA) in medium
containing 10% fetal calf serum (FCS). After 24 h the cells were
transfected with the siRNA/expression vectors, and after an additional
24–48 h (experimentwithout or including siRNA treatment, respective-
ly) the transfected cells were selected for imaging by GFP ﬂuorescence.
Onlymono-nuclear cells with ‘normal’ size and shapewere imaged. The
cellswere imaged by anOlympus IX81microscope, using a 60X PlanApo
objective lens and 1.42 numerical aperture Orca-AG charge-coupled
device camera ﬁtted with rapid wavelength switching (Hamamatsu,
Bridgewater, NJ), and driven by the cellR software. The microscope is
equipped with an on-scope incubator which includes temperature and
CO2 control (Life Imaging Services, Reinach, Switzerland). Temperature
was controlled at 37 °C in a 5% CO2 atmosphere. Pictures were taken
with an exposure time of 10–100 ms (depending on the cell type) and
a frame rate of 0.8 s. Movie sequenceswere deconvolved using the Huy-
gens Essential software (Scientiﬁc Volume Imaging, Hilversum, The
Netherlands).2.3. Data analysis
MTswere automatically tracked using PlusTipTracker software, ver-
sion 1.1.3. The algorithms for this analysis are described in detail in
Matov et al. [30] and Applegate et al. [31]. To cluster collinear growth
tracks that belong to the same MT PlusTipTracker requires several con-
trol parameters for tracking. The same parameter set was used for all
movies in the dataset: maximum gap length, 30 frames; minimum
track length, 3 frames; search radius range, 1–5 pixels; maximum for-
ward angle, 30°; maximum backward angle, 10°; maximum shrinkage
factor, 1.5; ﬂuctuation radius, 2 pixels; and pixel size, 107.5 nm. To in-
clude in the Bgap group only presumable real shrinkage event, only
Bgap that have a speed faster than the median of the Fgap speed were
considered as Bgap. The remaining Bgaps were re-classiﬁed as Fgap
events.
2.4. Statistical analysis
For statistical analyses, the plusTipTestDistrib function of the
PlusTipTracker package was used. For most of the dynamic parameters,
the program collects and analyzes all the data from all the cells for each
treatment. For parameters for which the program performs analysis per
cell (dynamicity and relative time spent in the three phases), the cells'
values were analyzed by t-test for signiﬁcant differences between the
treatments.
2.5. Western analysis
Western blot analysis was performed as described previously [9]
using rabbit polyclonal antibodies against full-length Nek7 protein.
The antibodies against actin and β-tubulin were purchased from DHSB.
3. Results
3.1. Nek7 knockdown by siRNA altered microtubules dynamics
It has been shown previously that downregulation of Nek7 protein
levels by siRNA results in various mitotic-related defects including dis-
organized and fragile spindle, reduced spindle α-tubulin intensity,
spindle assembly checkpoint and metaphase arrest, and multinuclear
cells [18–20]. To examine whether Nek7 deﬁciency affects interphase
MT dynamics we ﬁrst diminished Nek7 levels by siRNA treatment.
HeLa cells were transfected with Nek7-speciﬁc siRNA (siNek7-1) or
with scrambled siRNA (siScrambled) [18] in combination with EB3-
GFP construct [29]. As shown previously [18], siNek7-1 treatment spe-
ciﬁcally reduced Nek7 protein to about 10% of its normal levels
(Fig. 1A). 48 h following transfection, the MT comets were visualized
using time-lapse microscopy (Supplementary video 1). The recently
developed, PlusTipTracker automated tracking system [31] allowed
the simultaneous chasing of thousands of MT tracks (Fig. 1B), enabling
thorough statistical analysis. The software was able to detect and track
33,135 sub-tracks from 38 si-Scrambled-treated cells, and 31,970
sub-tracks from 51 siNek7-1-treated cells (each from three different
experiments). Comparison of MT growth speeds revealed that Nek7
siRNA treatment reduced the MT mean growth speed by about 14%
compared to the scrambled siRNA (from 11.8 to 10.1 μm/min)
(Fig. 1C and D; presented as histograms and as box plots, respectively).
Another important characteristic of the growth phase is its lifetime, or
the processivity of the MT growth. Interestingly, siRNA treatment in-
creased the mean duration of the MT growth events by about 6.9%
(from 5.1 to 5.5 s; Fig. 1E). Calculation of the mean growth length of
the growing MT sub-tracks, demonstrated a decrease in the overall
length by 12.7% (from 0.98 to 0.85 μm). All of these effects were highly
signiﬁcant (pb0.0001) (Table 1).
Although the+TIP protein EB3 labels only MT in the growth phase,
the PlusTipTracker software can also predict pause and shrinkage
Fig. 1. Nek7knockdownby siRNAalteredmicrotubules dynamics. A.Nek7 levels inHeLa cells following transfectionwith siNek7-1or siScrambled, combinedwithEB3-GFP construct. Cellswere
extracted 48 h post transfection. Actin served as a loading control. B. Color-codedmap of growth lifetime sub-tracks of a siScrambled treated cell. Bar, 10 μm. The color bar represents the life-
timesof thegrowth tracks in seconds. C. Growth speeddistributionhistogramof theEB3-GFP comets following transfectionof siNek7-1 (red), and siScrambled (blue) constructs inHeLa cells. D–
G. Box plot descriptions of growth speeds, growth lifetimes, Bgap speeds and Bgap lifetime distribution. The borders of the boxes indicate 25th and 75th percentile and the internal line the
medians. Green lines extend to 1.5 times of the interquartile range, and red dots indicate outliers beyond this range.
1106 S. Cohen et al. / Biochimica et Biophysica Acta 1833 (2013) 1104–1113parameters by linking two spatially and temporally adjacent growth
sub-tracks into one assumed compound track [31]. The pause is deﬁned
as the period in which no apparent growth or shrinkage occurs. As
discussed by Applegate et al. [31], deﬁnition of a gap between two suc-
cessive sub-tracks as a pause is inherently dependent on discrimination
between three situations: a real MT growth pause, temporary comet
disappearance from the detectable plan, or successive short catastrophe
phase followed by a growth period. The software uses several assump-
tions aboutMT growth behavior to discriminate between these options.
By applying these parameters in our analyses we observed a barely sig-
niﬁcant difference between the scrambled and siNek7-1 treatments in
the mean lifetime of the pause (Table 1). However, highly signiﬁcantdifferences were observed in the catastrophe parameters. Catastrophe
events parameters are estimated by the program by calculating “back-
ward gaps” (Bgap) data, namely measuring catastrophe events
connected to adjacent rescue and growth phase. The Bgaps events
are deﬁned by their speed, duration and their length. Knockdown
of Nek7 levels by the siRNA treatment, resulted in 12.9% reduction
in Bgap mean speed compared to the control siRNA (from 13.6 to
11.8 μm/min) (Fig. 1F). The duration of the catastrophe events was
shorter in the siNek7-1 treated cells, as indicated by the much lower
mean Bgap lifetime (reduction of 19.3%, from 7.7 to 6.2 s) (Fig. 1G). As
a consequence of the lower velocity and the shorter duration, the mean
length traveled by the Bgap was much shorter in the siNek7-1 treated
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1107S. Cohen et al. / Biochimica et Biophysica Acta 1833 (2013) 1104–1113cells (reduction of 29.6%, from 1.53 to 1.07 μm). All of these effects were
highly signiﬁcant — pb0.0001 (Table 1).
3.2. The effects of Nek7 overexpression on MT dynamics are the inverse of
Nek7 downregulation
To verify that thedepletion of Nek7 itself caused the observedMTdy-
namics phenotypes and that theywere not due to off-target effects of the
siRNA, we attempted to overexpress Nek7 RNA in siNek7-1 treated cells.
The siNek7-1 used in the experiments described above targeted con-
served sequences in mouse and human Nek7 RNA, and as expected it
was found to downregulate also ectopic murine Nek7 expression (not
shown). We thus treated the HeLa cells with a different siRNA against
the human Nek7 according to O'Regan and Fry [20] (designated hereon
siNek7-2). There are two mismatches between this siRNA sequence
and the corresponding mouse sequence, and siNek7-2 was found to
downregulate the endogenous human Nek7 gene in HeLa cells, but not
the overexpressed murine cDNA (Fig. 2A). siNek7-2 downregulation of
the endogenous Nek7 protein was less robust compared to siNek7-1
(leaving about 32%of the normal levels), and its inﬂuence onMTdynam-
ics recapitulated the siNek7-1 inﬂuence, but with somewhat weaker
magnitude (Fig. 2B–E middle panels, Table 1 and data not shown). Im-
portantly, overexpression of the murine myc-Nek7 construct in HeLa
cells co-transfected with siNek7-2 (and EB3-GFP), rescued the MT dy-
namics phenotypes. The mean growth and Bgap speeds, as well as the
Bgapmean lifetime of the co-transfected cells, were not signiﬁcantly dif-
ferent from the control cells (co-transfected with si-scrambled, c-myc
control plasmid and EB3-GFP) (Fig. 2B, C, E lower panels). The mean
growth lifetime was somewhat lower in the siNek7-2; Nek7 over-
expressed cells (as opposed to the effect of Nek7 downregulation)
(Fig. 2D) (Table 1), probably due to the net elevation of Nek7 protein
levels, as the overexpressed exogenous protein levels were higher than
the levels of the endogenous (silenced) gene (Fig. 2A).
We next sought to determine whether ectopic overexpression of
Nek7, without silencing of the endogenous gene, would achieve the op-
posite effects to Nek7 downregulation (Fig. 3A) (Videos S2 and S3). In-
triguingly, overexpressed cells demonstrated the reversal of all major
downregulation characteristics. The mean growth speeds were elevat-
ed by 20.6% (from 10.7 to 12.9) (Fig. 3B, C), and the mean growth life-
timewas reduced by 9.9% (from 6.1 to 5.5) (Fig. 3D). As opposed to the
downregulation, in the cells overexpressing Nek7 the mean growth
length was elevated by 7.1% (from 0.70 to 0.75 μm) (Table 1). As is
the case with Nek7 downregulation, the pause duration (Fgap mean
lifetime) was only slightly affected by Nek7 overexpression (Table 1).
The Bgap characteristics were also the inverse of the downregulation
characteristics. The Bgap speed increased by 35.8% (from 12.0 to
16.3 μm/min) (Fig. 3E), the mean lifetime increased by 30.1% (from
6.27 to 8.16 s) (Fig. 3F) and as a consequence themean Bgap length in-
creased dramatically by 80.2% (from 1.11 to 2.0 μm) (Table 1).
3.3. Nek7 mutant mouse embryonic ﬁbroblasts recapitulated the Nek7
downregulation effect on microtubule dynamics
Werecently created targetedmutants for Nek7 [21]. Themutants die
perinatally, and mouse embryonic ﬁbroblast (MEF) derived from the
mutants demonstrated frequent cytokinesis failure and aneuploidy
[21]. To explore the inﬂuence of Nek7 absence on MT dynamic instabil-
ity in this system, we transfected the EB3-GFP construct to mutant MEF
and to their littermate's MEF cells. As expected, no Nek7 protein could
be seen in the mutant MEFs (Fig. 4A). Analysis of MT tracks revealed
that in all of the dynamics parameters Nek7 absence mimicked siRNA
knockdown. Counterintuitively, the effect of the loss of Nek7was some-
what moderate compared to the knockdown. Milder inﬂuence of the
null Nek7 mutation, compared to the siRNA downregulation, has been
reported and discussed before [21]. Thus, as is the case with the down-
regulation, the mean growth speed in the mutant cells compared to wt
Fig. 2. Nek7 overexpression rescued siRNA downregulation. A. Nek7 levels in HeLa cells following co-transfection with siScrambled and c-myc vector, siNek7-2 and c-myc vector or siNek7-2
and c-myc-Nek7 expression vector. Note that overexpressed Nek7 is up-shifted in the gel due to the myc-tag tail. EB3-GFP construct was added to all transfections. Cells were imaged and
extracted 48 h post transfection. Actin served as a loading control. B–E. Box plot descriptions of growth speeds, Bgap speeds, growth lifetimes and Bgap lifetime distribution. For boxes and
lines' description see legends for Fig. 1.
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evated (by 13.2%) (Fig. 4C), and the mean growth length was reduced
(by 5.7%) (in all cases; pb0.0001) (Table 1). The Fgap lifetime (pause)
was not affected, while the mean Bgap speed was only slightly reduced
(by 4.55%, not signiﬁcant) (Fig. 4D), its lifetime was reduced (by 5.2%;
p=0.04) (Fig. 4E), and its mean length was more rigorously reduced
(by 11.5%; pb0.0001) (Table 1).
3.4. Comparative analysis of microtubule dynamics characteristics in the
four experimental groups
Next, we utilized the PlusTipTracker software to compare additional
MT dynamic characteristics in all of the experiments described above.
The growing MT could be divided into four sub-populations according
to their comparative speed and growth lifetime: A. slow and short
lived, B. slow and long lived, C. fast and short lived, and D. fast and
long lived. The PlusTipTracker software's tool Quadrant Scatter Plot
was used to draw the comparative distribution of the growing MT
from the experiments described above into these four groups. The
fast and slow groups were split according to mean growth speed
(11.9 μm/min; the 50% percentile) and the short-lived versus long-
lived according to mean lifetime (5.1 s; the 50% percentile) of the
HeLa controls (Fig. 5A, B), or the mean for wt MEF cells (Fig. 5C). As
can be seen in Fig. 5B, the percentages of fast speed sub-tracks (both
short and long lived; yellow and blue, respectively) were reduced com-
pared to the control, while the percentages of the slow sub-tracks (red
and green) were elevated. The same pattern was observed in acomparison of the Nek7mutant MEFs to the wt MEFs (Fig. 5C). The rel-
ative percentages were exactly the inverse in HeLa cell overexpressing
Nek7, while overexpressing Nek7 with simultaneous downregulation
of the endogenous Nek7 protein, yielded similar percentages to the
control treatment (Fig. 5B). Likewise, division of the Bgap sub-tracks
into the four sub-populations demonstrated a drop in the percentages
of fast sub-tracks and inverse pattern following overexpression of Nek7
(Supp. Fig. 1).
The levels of Nek7 could affect the MT velocities and persistence by
changing these parameters throughout the entire MT network. Alterna-
tively, they could speciﬁcally affect central or peripheralMT. Preferential
impact on peripheral MT (mainly on the cell's leading edge) has been
reported for Rac1 GTPase and for Microtubule afﬁnity-regulating kinase
2 [32]. To measure the distribution of the velocities and growth lifetime
in the cell sub-regionswe utilized the “sub-region of interest” (sub-ROI)
tool of the PlusTipTracker program. Each of the analyzed cells was auto-
matically divided by the program to two equal-sized areas, central and
peripheral, and the velocities and time life of the MT was measured in
these areas. In accordance with previous ﬁndings [31], the velocity of
the central MT was faster than the peripheral ones (by about 5%; not
shown). However, Nek7 levels inﬂuenced both the central and periph-
eral speeds (and duration) by the same extent (Fig. 6, and not shown).
Thus, Nek7 effect on the MT dynamics is globally distributed within
the MT network.
An important characteristic of the MT dynamics is the relative time
spent in the three phases: growth, pause and shrinkage. In the control
HeLa cells, the percentage of time spent by theMTswas72.1% in growth,
Fig. 3. Nek7 overexpression resulted in inverse dynamic parameters compared to its downregulation. A. Nek7 levels in HeLa cells following ectopic overexpression of c-myc-Nek7 construct.
Cells were extracted 24 h post transfection. B. Growth speed distribution histogram of the EB3-GFP comets following transfection of c-myc vector (blue) or c-myc-Nek7 expression vector
(red) in HeLa cells. C–F. Box plot descriptions of growth speeds, growth lifetimes, Bgap speeds, and Bgap lifetime distributions. For boxes and lines' descriptions see legends for Fig. 1.
Fig. 4. Nek7mutantmouse embryonic ﬁbroblasts recapitulated the Nek7 downregulation effect onmicrotubule dynamics. A. Nek7 levels in wtMEF cells and inMEF cells derived from homo-
zygote mice for Nek7 knockout. Tubulin served as a loading control. To all transfections EB3-GFP construct was added. Cells were extracted 24 h post transfection. B–E. Box plot descriptions
growth speeds, growth lifetimes, Bgap speeds and Bgap lifetime distributions. For boxes and lines' descriptions see legends for Fig. 1.
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Fig. 5. Nek7 inﬂuence onMTdynamics— general comparisons. A. Quadrant scatter plot dividing the points on the graph to four quadrants based onmean growth speed (50% percentile; on the
X axis), andmean growth lifetime (50% percentile; on the Y axis) of the control experiments performed inHeLa cells. Each point represents one growth sub-track. The four sub-populations are
color-coded: slow and short-lived (red), fast and short-lived (yellow), slow and long-lived (green) and fast and long-lived (blue). The same colors serve to represent the four populations in B
and C. The plot portrays, as an example, the distribution of the sub-tracks in the siScrambled control treatment. B. Proportions of the four growth sub-tracks populations in the indicated exper-
iments performed inHeLa cells. C. Proportions of the four growth sub-tracks populations in thewt andmutantMEF cells. D. Histograms depicting the relative time spent in growth, pause (Fgap)
and catastrophe (Bgap) (*, p valueb0.05 compared to thematching control). E. Histograms showing the calculated dynamicity of theMT in the different treatments. The p value is also shown.
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trophe). It should be noted that the calculated ‘time spent in Bgap’ is an
underestimate as only backward gaps that were proceeded by deﬁned
growth sub-track were considered as Bgaps. The percentages were sig-
niﬁcantly different in the siNek7-1 treatment. The time spent in growth
was elevated by 9.4% (to 78.9% of the total time), while the time spent in
the Fgap phase was reduced by 16.1% (to 17%), and the time spent in
Bgap was dramatically reduced by 46.2%, and the MTs spent only 4.1%
of their time in Bgap (Fig. 5D). The direction of Nek7 deﬁciency inﬂu-
ence in the MEF cells on the distribution of the MT in the different
phases recapitulate Nek7 downregulation and the time spent in growth
was increase (by 11%) on the expense of reduction in the time spent in
pause (by 22.3%) and in shrinkage (reduced by 36.3%) (Fig. 5D). Inter-
estingly, the relative duration spent by the MT from the Nek7
overexpressing cells in the various phases displayed strict reversal of
the downregulated/knockout cells. The relative time spent at growth
was reduced by 8.4% (to 70.7%), the time spent in Fgap (reﬂecting
pause) was elevated by 21.3% (to 21.7%), and the relative time spent
at Bgap (shrinkage) grew considerably by 55.5% (to 7.6% of the total
time).
Finally, a general and useful value is the dynamicity of theMT calcu-
lated as the combined length of all gap-containing tracks (growth plus
shrinkage) over their combined lifetimes. Higher dynamicity enables
faster adjustment of the MT to their surrounding microenvironment,and an alteration in MT dynamicity is a critical event in tumorigenesis
[33]. The dynamicity was reduced by about 17% following the siNek7
treatments and in the Nek7 mutant MEF, while ectopic Nek7 over-
expression resulted in 24.9% elevation in the MT dynamicity (Table 1).
4. Discussion
The present study demonstrates concordant phenotypes produced
by two independent siRNAs and by Nek7-mutant MEF cells, successful
rescue of the siRNA phenotype by Nek7 co-overexpression, and inverse
effect of Nek7 ectopic overexpression on MT dynamics parameters.
Nek7 accelerates both growth anddepolymerization velocities, expands
the time spent in catastrophe and steps up the general MT dynamicity.
The effects are highly signiﬁcant statistically. However, the inﬂuences of
the modiﬁcations of Nek7 levels on MT behavior are moderate. A com-
parative analysis of the inﬂuence of lowering the levels of several
well-studied regulators of MT dynamics on MT growth pace and life-
time, executed using the PlusTipTracker program, observed a wide
spectrum of impacts on these parameters [32]. siRNA-induced reduc-
tion in the levels of several factors including the +TIP rescue factor
CLIP115 and the MT stabilizer and modulator Doublecortin exhibited
quite dramatic slower MT growth, while the MT growth enhancer
microtubule-associated protein 1S and the MT stabilizer STOP reduced
the MT velocity to a similar extent as siNek7-1 (Nishimura et al. [32]
Myc
Myc-Nek7
Slow Fast Slow Fast Merge
short-lived long-lived
Fig. 6. Cellular localization ofMT subpopulations classiﬁed by their growth speed and lifetime. Positions of growth sub-trackswithin the cell according to their deﬁnition as slowand short-lived,
fast and short-lived, slow and long-lived and fast and long-lived. The color code is as in Fig. 5. Right column:merged picturesmarkedwith the border between internal and peripheral areas by
the sub-ROI tool of the PlusTipTracker (50%:50%). Bar, 15 μm.
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velocity to a similar extent as observed formicrotubule-afﬁnity regulat-
ing kinase 2 (MARK2) and the MT stabilizer MAP2, but much less than
the MT catastrophe-promoting protein ACF7 or theMT growth stabiliz-
er CLASP2 [32]. Fine-tuning ofMT velocities (and dynamics) could be an
inherent characteristic of Nek7 (and presumably of other Nek kinases).
Alternatively, the modest effect of Nek7 on MT pace could be due to a
functional overlap with other Nek kinases. Interestingly, while for
most proteins there is a correlation between their tendency to reduce
MT velocity and to reduce MT growth lifetime (or enhancing both)
[34], changes in Nek7 levels have opposite effects on MT growth and
lifetime. Such opposing effects were also observed for the MT
destabilizing protein NDEL1 [34].
Fine regulation of MT dynamics is critical for proper execution of mi-
tosis [35,36]. Slower MT dynamics could delay attachment of MT to the
kinetochores in prometaphase, and could lead to mitotic spindle abnor-
malities and chromosomesmissegregation [37]. Indeed, downregulation
of Nek6, 7, or 9 signaling leads to defectivemitotic bipolar spindle orga-
nization, reduced spindle MT density, and inaccurate chromosome seg-
regation [6,17–20]. Consistently, high tendency for cytokinesis failures
and aneuploidy was observed in mouse embryonic ﬁbroblast derived
from knockout mice for Nek7 [21]. It should be noted that Nek7 siRNA
treatment was shown to slow interphase MT nucleation from the cen-
trosome [19,23], and that Nek9, the upstream regulator of Nek6/7, is
involved in both the chromosomal and centrosomal pathways of MT
nucleation and organization [38], probably by affecting γ-tubulin
recruitment to the centrosome [24]. These phenotypes could be related
mechanistically to the slower MT growth velocity documented herein,
and might contribute to the misregulation of spindle organization.
Interestingly, a hallmark of several protist and mammalian Nek kinases
is regulation of cilium/ﬂagellum formation, length and severing
[5,8,9,21,39,40]. As the cilium axoneme is a MT-based cytoskeleton,involvement of Nek kinases inMT dynamics could directly inﬂuence cil-
ium characteristics. Supporting the connection between MT dynamics
and cilium length, a recent report demonstrated that the availability
of soluble tubulin dictates cilium length [41]. MT dynamic instability
also inﬂuences a host of cellular activities including cell motility [42],
neuronal plasticity [43], cell polarization [44] and intracellular trafﬁck-
ing [45]. It will be prudent to ascertain whether these activities are af-
fected in mutants for Nek7 and in other mammalian Nek kinases.
A plethora of different mechanisms were reported to be involved in
spatial and temporal control of MT dynamics instability, and the under-
lyingmolecular mechanisms bywhichNek7 affectMT dynamics are not
clear. However, several reported observations concerning Nek7 and
other Nek kinases allow us to envision potential molecular scenarios:
A. Nek6 and 7 have been shown to immunoprecipitate and to phosphor-
ylate α and β-tubulin in vitro [20]. Tubulin phosphorylation by Nek
kinases is evolutionary conserved, as it has also been documented for
Arabidopsis Nek6 (which is mostly related to the mammalian Nek4
kinase). Arabidopsis mutants for Nek6 exhibit irregular organization of
cortical MT arrays and organ development [46,47]. However, the func-
tional signiﬁcance of interphase tubulin phosphorylation is still elusive
(for review [48]). B. In the trypanosomatid Crithidia fasciculate a
NIMA-related kinase, CfNek, exhibited tubulin polyglutamylation activ-
ity [4]. Tubulin glutamylation can have either a MT-stabilizing or
destabilizing effect, probably dependingon the structure of the glutamyl
side chain and the available repertoire of MT modifying molecules [48].
Importantly in this regard, polyglutamylation is abundant on MT of ax-
onemes, centrioles and basal bodies, structures known to be major tar-
gets of Nek kinases. C. Nek7 can phosphorylate MT associated proteins
or MT motors, leading to alteration in their activity or stability. A high
throughput screen for Nek6-interacting proteins revealed Nek6 binding
to Echinoderm microtubule-associated protein-like (EML) 2, 3 and 4
[49]. The mammalian EML family members are involved in mitotic and
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motor proteins of the kinesin superfamily (and especially of the kinesin-
8 family) were reported to control MT length and dynamics (for review
[53]). Nek6 andNek7 interact and phosphorylate the kinesinmotor pro-
tein, Eg5 [54]. Eg5 has well documented roles in mitotic bipolar spindle
formation [55]. However, it is also highly expressed in postmitotic neu-
rons, in which it regulates axonal growth [56], raising the possibility of a
role in interphase MT dynamics.
Chromosomal instability and aneuploidy are hallmarks of solid tu-
mors, and perturbed MT dynamic instability could contribute to these
states by affecting kinetochore–MT attachment dynamics, or by induc-
ing cytokinesis failure [57]. The mitotic MT network is the major target
of antimitotic drugs (for review [58]),which normally affectMT dynam-
ics rather thanMTpolymerization [59]. Thus,MT instability is intimately
connected to both tumorigenesis and cancer treatment. Several mam-
malianNekkinases, includingNek6 andNek7,were implicated in cancer
formation [60–63]. We hypothesize that some of the oncogenic inﬂu-
ences of the Nek kinases may be mediated through the modulation of
MT dynamics. Interestingly in this regard, Nek4 was reported to be de-
leted in lung cancers, and Nek4 deﬁciency by siRNA treatment antago-
nizes the activity of taxol (a MT stabilizing agent), while it agonizes
the effect of vincristine (a MT destabilizer) [64]. However, direct dem-
onstration of MT dynamics alteration by Nek4 has not been shown.
TheNIMA-related kinase (Nek) family has only one representative in
fungi, while in several protists and in higher metazoan, the family has
branched extensively having as many as 56 active members in Giardia
[65] and 11 members in mammalians. It is tempting to speculate that
the diversiﬁcation of the Nek family during evolution contributed to in-
tricate control of the MT network, and that the different Nek adopted
nuanced functions in MT dynamics regulation. Systematic exploration
of the involvement of the different mammalian Nek kinases in MT dy-
namics, combined with the identiﬁcation of the MT ingredients with
which they interact should enable testing of this hypothesis.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.12.021.
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